Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients

NCT04360551 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped Decrease in COVID-19 cases locally

Conditions

COVID-19

Interventions

DRUG: Telmisartan 40mg
DRUG: Placebo

Sponsor

University of Hawaii

Collaborators

[object Object]